M&A Deal Summary

Organon Acquires Alydia Health

On June 16, 2021, Organon acquired medical products company Alydia Health for 240M USD

Acquisition Highlights
  • This is Organon’s 1st transaction in the Medical Products sector.
  • This is Organon’s largest (disclosed) transaction.
  • This is Organon’s 1st transaction in the United States.
  • This is Organon’s 1st transaction in California.

M&A Deal Summary
Date 2021-06-16
Target Alydia Health
Sector Medical Products
Buyer(s) Organon
Deal Type Add-on Acquisition
Deal Value 240M USD

Target

Alydia Health

Menlo Park, California, United States
website
Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding. It develops Jada System, a medical device for abnormal postpartum uterine bleeding and postpartum hemorrhage (PPH), the number one cause of maternal death. The company's single-minded focus is to radically improve the treatment path for postpartum hemorrhage from the traumatic, life-altering condition that it is today. Alydia Health was formed in 2011 and is based in Menlo Park, California.

Search 193,711 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Organon

Jersey City, New Jersey, United States

website

Category Company
Sector Healthcare Services
Revenue 8.1B USD (2020)
DESCRIPTION

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. The company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast-growing international markets. Organon is based in Jersey City, New Jersey.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 2
State (California) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 2
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-11 Forendo Pharma

Turku, Finland

Forendo Pharma is a clinical-stage drug development company focused on novel treatments in women’s health. Forendo Pharma is based in Turku, Finland.

Buy $75M
Mergr

Product

Company

Legal